ArticleBioresources and bioprocessing2026
Engineering Thermothelomyces heterothallica for cellobionate production.
Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this study, a thermophilic cellulolytic filamentous fungus Thermothelomyces heterothallica was engineered for direct production of cellobionic acid (CBA) from alkali-pretreated wheat straw without the addition of external cellulases. The CBA bioproduction pathway was established through sequential disruption of genes involved in cellobiose and CBA catabolism, including eight β-glucosidases, one cellobiose/cellobionate phosphorylase, and two putative cellobionate transporters using a ribonucleoprotein (RNP)-based CRISPR-Cas9 system. The resulting T. heterothallica strain, TH11, was able to produce cellobionate from cellobiose and pretreated wheat straw at a high yield. Further optimization of fermentation pH using 50 mM citrate buffer (pH 6.0) increased the final cellobionate concentration. Fermentation temperature optimization showed that 43 °C accelerated substrate conversion without significantly affecting final titers. The engineered strain, TH11 produces 64 mM of cellobionate in 5 days. The cellulose conversion was about 88%, and the yield of the cellobionate from the consumed cellulose was about 96%. The new strain provides a promising platform for direct bioconversion of lignocellulosic biomass into value-added aldonic acids without any enzyme addition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.